Mayo Study Results Due Out At Any Time. Potential takeover target at $5.00. Due diligence. Recent events in Japan make cancer detection a huge concern.Radient's Poker Face Is Actually Quite Tellinghttp://biomedreports.com/2011031565020/radients-poker-face-is-actually-very-telling.htmlDr. Robert Beart’s Presentation on Onku-Surehttp://www.youtube.com/watch?v=J27Id9Bl5PkWho Is Dr. Robert Beart Note: He recently joined Radient’s Board of Directorshttp://ccnt.hsc.usc.edu/colorectal/beartcv.aspx
Study results should be out by Friday.GLTA
Substantial upside here.